Stock Taper
EARNINGS CALL ARCHIVE 2 CALLS ON FILE
ONC — BeOne Medicines AG
NASDAQ
FULL STOCK PAGE →

Q3 2025 Earnings Call Summary

NOV 6, 2025
REVENUE
$1.41B +7.4%
NET MARGIN
8.8% +1.7 PTS
EPS
$14.69 +1588.5%
FREE CASH FLOW
$354.5M +77.4%

No summary has been written for this call yet.